Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Therapeutics and Clinical Risk Management

ISSN: 1178-203X


Archive: Volume 15, 2019

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis

Migliore A, Gigliucci G, Petrella RJ, Bannuru RR, Chevalier X, Maheu E, Raman R, Herrero-Beaumont G, Isailovic N, Matucci Cerinc M

Therapeutics and Clinical Risk Management 2019, 15:1479-1482

Published Date: 23 December 2019

Combined Direct Posterior Split-Gastrocnemius Approach for the Posterolateral Tibial Plateau Involved Fractures

Chen C, Huang L, Zheng H, Liu L, Chen Y, Xie X, Wang Y

Therapeutics and Clinical Risk Management 2019, 15:1461-1467

Published Date: 19 December 2019

Acute Intermittent Porphyria: Current Perspectives And Case Presentation

Spiritos Z, Salvador S, Mosquera D, Wilder J

Therapeutics and Clinical Risk Management 2019, 15:1443-1451

Published Date: 16 December 2019

Increased Surgical Duration Associated With Prolonged Hospital Stay After Isolated Posterior Cruciate Ligament Reconstruction

Swindell HW, Boddapati V, Sonnenfeld JJ, Trofa DP, Fleischli JE, Ahmad CS, Popkin CA

Therapeutics and Clinical Risk Management 2019, 15:1417-1425

Published Date: 10 December 2019

Unusual Presentation Of Kawasaki Disease With Gastrointestinal And Renal Manifestations

Lazea C, Man O, Sur LM, Serban R, Lazar C

Therapeutics and Clinical Risk Management 2019, 15:1411-1416

Published Date: 5 December 2019

Severe Atopic Dermatitis In Spain: A Real-Life Observational Study

Sicras-Mainar A, Navarro-Artieda R, Armario-Hita JC

Therapeutics and Clinical Risk Management 2019, 15:1393-1401

Published Date: 2 December 2019

Comparison Of Three Different Treatment Methods For Cesarean Scar Pregnancy

Fei H, Jiang X, Li T, Pan Y, Guo H, Xu X, Shu S

Therapeutics and Clinical Risk Management 2019, 15:1377-1381

Published Date: 27 November 2019

Gamma Knife Radiosurgery For Brain Vascular Malformations: Current Evidence And Future Tasks

Hasegawa H, Yamamoto M, Shin M, Barfod BE

Therapeutics and Clinical Risk Management 2019, 15:1351-1367

Published Date: 18 November 2019

Incidence Of Clostridium difficile Infection And Associated Risk Factors Among Hospitalized Children In Qatar

Khalil A, Hendaus MA, Elmagboul E, Mohamed A, Deshmukh A, Elmasoudi A

Therapeutics and Clinical Risk Management 2019, 15:1343-1350

Published Date: 18 November 2019

Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused By Coronary Heart Disease: Data Of First Event And Recurrent Event

Tian J, Yan J, Zhang Q, Yang H, Chen X, Han Q, Han R, Ren J, Zhang Y, Han Q

Therapeutics and Clinical Risk Management 2019, 15:1333-1341

Published Date: 14 November 2019

Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified

Baum SJ, Wade RL, Xiang P, Arellano J, Cerezo Olmos C, Nunna S, Chen CC, Carter CM, Desai NR

Therapeutics and Clinical Risk Management 2019, 15:1325-1332

Published Date: 13 November 2019

Combined Corneal Wedge Resection And Corneal Cross-Linking For Pellucid Marginal Degeneration: A First Report

Kymionis G, Voulgari N, Samutelela E, Kontadakis G, Tabibian D

Therapeutics and Clinical Risk Management 2019, 15:1319-1324

Published Date: 12 November 2019

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm

Wang Y, Patel A, Douglas RS

Therapeutics and Clinical Risk Management 2019, 15:1305-1318

Published Date: 11 November 2019

Predictors Of Postoperative Lower Urinary Tract Symptoms Improvements In Patient With Small-Volume Prostate And Bladder Outlet Obstruction

Li XD, Wu YP, Ke ZB, Lin TT, Chen SH, Xue XY, Xu N, Wei Y

Therapeutics and Clinical Risk Management 2019, 15:1291-1304

Published Date: 7 November 2019

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review

Yasuda Y, Nagano T, Tachihara M, Chihara N, Umezawa K, Katsurada N, Yamamoto M, Sekiguchi K, Kobayashi K, Nishimura Y

Therapeutics and Clinical Risk Management 2019, 15:1283-1289

Published Date: 1 November 2019

Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations

Baharudin A, Abdul Latiff AH, Woo K, Yap FBB, Tang IP, Leong KF, Chin WS, Wang DY

Therapeutics and Clinical Risk Management 2019, 15:1267-1275

Published Date: 31 October 2019

Frailty In Patients Undergoing Vascular Surgery: A Narrative Review Of Current Evidence

Czobor NR, Lehot JJ, Holndonner-Kirst E, Tully PJ, Gal J, Szekely A

Therapeutics and Clinical Risk Management 2019, 15:1217-1232

Published Date: 17 October 2019

External Validation Of The Surgical Mortality Probability Model (S-MPM) In Patients Undergoing Non-Cardiac Surgery

Kazimierczak S, Rybicka A, Strauss J, Schram M, Kazimierczak A, Grochans E

Therapeutics and Clinical Risk Management 2019, 15:1173-1182

Published Date: 4 October 2019

Clinical Pathways For Pancreatic Surgery: Are They A Suitable Instrument For Process Standardization To Improve Process And Outcome Quality Of Patients Undergoing Distal And Total Pancreatectomy? - A Retrospective Cohort Study

Téoule P, Römling L, Schwarzbach M, Birgin E, Rückert F, Wilhelm TJ, Niedergethmann M, Post S, Rahbari NN, Reißfelder C, Ronellenfitsch U

Therapeutics and Clinical Risk Management 2019, 15:1141-1152

Published Date: 1 October 2019

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis

Xie W, Luo Y, Liang X, Lin Z, Wang Z, Liu M

Therapeutics and Clinical Risk Management 2019, 15:1129-1140

Published Date: 24 September 2019

Photosensitivity reactions in the elderly population: questionnaire-based survey and literature review

Korzeniowska K, Cieślewicz A, Chmara E, Jabłecka A, Pawlaczyk M

Therapeutics and Clinical Risk Management 2019, 15:1111-1119

Published Date: 12 September 2019

Idiopathic pulmonary fibrosis and GERD: links and risks

Ghisa M, Marinelli C, Savarino V, Savarino E

Therapeutics and Clinical Risk Management 2019, 15:1081-1093

Published Date: 5 September 2019

Atherosclerosis risk assessment in patients with chronic obstructive pulmonary disease: a case-control study

Sharma H, Kapur P, Jalali RK, Dubey K

Therapeutics and Clinical Risk Management 2019, 15:1061-1071

Published Date: 29 August 2019

Autosomal dominant polycystic kidney disease: updated perspectives

Rastogi A, Ameen KM, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M, Lerma EV

Therapeutics and Clinical Risk Management 2019, 15:1041-1052

Published Date: 26 August 2019

Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients

Dai J, Zhao J, Du Y, McNeil EB, Chongsuvivatwong V

Therapeutics and Clinical Risk Management 2019, 15:979-989

Published Date: 8 August 2019

The importance of early identification of infusion-related reactions to monoclonal antibodies

Cáceres MC, Guerrero-Martín J, Pérez-Civantos D, Palomo-López P, Delgado-Mingorance JI, Durán-Gómez N

Therapeutics and Clinical Risk Management 2019, 15:965-977

Published Date: 1 August 2019

Tracheal intubation with the rigid tube for laryngoscopy – a new method [Retraction]

Marchis IF, Radeanu D, Cosgarea M

Therapeutics and Clinical Risk Management 2019, 15:957-958

Published Date: 29 July 2019

Glioma-associated radiation retinopathy treated successfully with aflibercept

Karagiannis D, Kontomichos L, Georgalas I, Peponis V, Antoniou E, Parikakis E

Therapeutics and Clinical Risk Management 2019, 15:937-941

Published Date: 26 July 2019

Neutrophil–lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study

Zhang Y, Zou P, Gao H, Yang M, Yi P, Gan J, Shen Y, Wang W, Zhang W, Li J, Liu P, Li L

Therapeutics and Clinical Risk Management 2019, 15:911-919

Published Date: 24 July 2019

Fentanyl vs fentanyl-dexmedetomidine in lumbar foraminotomy surgery

Abdul Hadi B, Sbeitan SM, Shakya AK

Therapeutics and Clinical Risk Management 2019, 15:885-890

Published Date: 15 July 2019

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

Menzella F, Montanari G, Patricelli G, Cavazza A, Galeone C, Ruggiero P, Bagnasco D, Facciolongo N

Therapeutics and Clinical Risk Management 2019, 15:869-875

Published Date: 10 July 2019

SGLT2 inhibitors and the changing landscape for treatment of diabetes

Liu S, Lam A, Wazir A, Cheema AN

Therapeutics and Clinical Risk Management 2019, 15:861-867

Published Date: 9 July 2019

Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital

Perrone V, Veronesi C, Nica M, Colombo D, Degli Esposti L, Castello R

Therapeutics and Clinical Risk Management 2019, 15:847-850

Published Date: 8 July 2019

Measuring serum beta2-microglobulin to predict long-term mortality in hemodialysis patients using low-flux dialyzer reuse

Dung NH, Kien NT, Hai NTT, Cuong PT, Huong NTT, Quyen DBQ, Tuan NM, Ha DM, Kien TQ, Dung NTT, Toan PQ, Vinh HT, Usui T, Thang LV

Therapeutics and Clinical Risk Management 2019, 15:839-846

Published Date: 9 July 2019

Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?

Németh B, Péter I, Boncz I, Jagicza A, Kiss I, Csergő Á, Kőszegi T, Kustán P, Horváth IG, Ajtay Z

Therapeutics and Clinical Risk Management 2019, 15:831-837

Published Date: 5 July 2019

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

Zhang H, Wu J, Zhang Z, Qian H, Wang Y, Yang M, Cheng Y, Tang S

Therapeutics and Clinical Risk Management 2019, 15:803-810

Published Date: 27 June 2019

Current status of venous thromboembolism development during the perioperative period for colorectal cancer, its prevention with enoxaparin, and monitoring methods

Aoki J, Sakamoto K, Takahashi R, Niwa K, Ishiyama S, Sugimoto K, Kamiyama H, Takahashi M, Kojima Y, Goto M, Tomiki Y, Iba T

Therapeutics and Clinical Risk Management 2019, 15:791-802

Published Date: 21 June 2019

Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria

Wen MY, Huang LQ, Yang F, Ye JK, Cai GX, Li XS, Ding HG, Zeng HK

Therapeutics and Clinical Risk Management 2019, 15:733-739

Published Date: 13 June 2019

Retroperitoneal robot-assisted laparoscopic upper pole heminephrectomy in adult patients with duplex kidneys

Qin J, Wang P, Jing T, Kong D, Ye S, Xia D, Wang S

Therapeutics and Clinical Risk Management 2019, 15:727-731

Published Date: 11 June 2019

Benign paroxsymal positional vertigo – recommendations for treatment in primary care

Wang YH, Chan CY, Liu QH

Therapeutics and Clinical Risk Management 2019, 15:719-725

Published Date: 11 June 2019

The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period

Zheng J, Nakamura T, Lu N, Hori K, Oguri M, Sakurai M, Ishizaki M

Therapeutics and Clinical Risk Management 2019, 15:701-709

Published Date: 12 June 2019

Overnight inpatient admission and revisit rates after pediatric adenotonsillectomy

Alsuhebani M, Walia H, Miller R, Elmaraghy C, Tumin D, Tobias JD, Raman VT

Therapeutics and Clinical Risk Management 2019, 15:689-699

Published Date: 6 June 2019

Improved perioperative quality of life in endoscopic sinus surgery by application of enhanced recovery after surgery

Wu X, Kong W, Zhu Q, Wang W, Xu H, Zhou S, Yang Q

Therapeutics and Clinical Risk Management 2019, 15:683-688

Published Date: 4 June 2019

Usefulness of bounce-back admission in monitoring the quality of practice in the emergency department

Tarumi Y, Harada T, Saito T, Hiroshige J, Dohi K

Therapeutics and Clinical Risk Management 2019, 15:647-658

Published Date: 6 May 2019

Rivaroxaban in atrial fibrillation cardioversion: an update

Lavalle C, Straito M, Caroli A, Piro A, Giunta G, Mariani MV, Fedele F

Therapeutics and Clinical Risk Management 2019, 15:613-626

Published Date: 2 May 2019

Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis

Leelawattanachai P, Montakantikul P, Nosoongnoen W, Chayakulkeeree M

Therapeutics and Clinical Risk Management 2019, 15:589-595

Published Date: 24 April 2019

Frequency of nonaspirin NSAID-relevant coexisting medical conditions in the primary-care setting: a retrospective database review

Bloom L, Boyle KE, Myers AE, Blacketer C, Weinstein R

Therapeutics and Clinical Risk Management 2019, 15:579-588

Published Date: 24 April 2019

Interprofessional safety reporting and review of adverse events and medication errors in critical care

Chapuis C, Chanoine S, Colombet L, Calvino-Gunther S, Tournegros C, Terzi N, Bedouch P, Schwebel C

Therapeutics and Clinical Risk Management 2019, 15:549-556

Published Date: 2 April 2019

Associated factors for depressive disorder in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis

Traisathit P, Moolkham K, Maneeton N, Thongsak N, Maneeton B

Therapeutics and Clinical Risk Management 2019, 15:541-548

Published Date: 1 April 2019

Fosfomycin: the characteristics, activity, and use in critical care

Hashemian SMR, Farhadi Z, Farhadi T

Therapeutics and Clinical Risk Management 2019, 15:525-530

Published Date: 27 March 2019

Drug-related problems in patients with rheumatoid arthritis

Ma SN, Zaman Huri H, Yahya F

Therapeutics and Clinical Risk Management 2019, 15:505-524

Published Date: 21 March 2019

Unmet needs in asthma

Gruffydd-Jones K

Therapeutics and Clinical Risk Management 2019, 15:409-421

Published Date: 14 March 2019

Chronic eosinophilic pneumonia: clinical perspectives

Crowe M, Robinson D, Sagar M, Chen L, Ghamande S

Therapeutics and Clinical Risk Management 2019, 15:397-403

Published Date: 13 March 2019

Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study

Yang HY, Guo DH, Jia WP, Zhu M, Xu YJ, Wang XY

Therapeutics and Clinical Risk Management 2019, 15:389-395

Published Date: 8 March 2019

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation

Kim HC, Kim TH, Rhee CK, Han M, Oh YM

Therapeutics and Clinical Risk Management 2019, 15:377-387

Published Date: 5 March 2019

Comprehensive evaluation of Manikin-based airway training with second generation supraglottic airway devices

Schmutz A, Bohn E, Spaeth J, Heinrich S

Therapeutics and Clinical Risk Management 2019, 15:367-376

Published Date: 1 March 2019

Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan

DiBonaventura MD, Shah-Manek B, Higginbottom K, Penrod JR, Yuan Y

Therapeutics and Clinical Risk Management 2019, 15:355-366

Published Date: 28 February 2019

Tracheal intubation with the rigid tube for laryngoscopy – a new method

Marchis IF, Radeanu D, Cosgarea M

Therapeutics and Clinical Risk Management 2019, 15:309-313

Published Date: 25 February 2019

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report

Uehara M, Nakamura Y, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H

Therapeutics and Clinical Risk Management 2019, 15:303-307

Published Date: 25 February 2019

Association of endothelial function with thin-cap fibroatheroma as assessed by optical coherence tomography in patients with acute coronary syndromes

Matsuzawa Y, Hibi K, Saka K, Konishi M, Akiyama E, Nakayama N, Ebina T, Kosuge M, Iwahashi N, Maejima N, Tamura K, Kimura K

Therapeutics and Clinical Risk Management 2019, 15:285-291

Published Date: 15 February 2019

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

Kawalec P, Śladowska K, Malinowska-Lipień I, Brzostek T, Kózka M

Therapeutics and Clinical Risk Management 2019, 15:275-284

Published Date: 13 February 2019

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S

Therapeutics and Clinical Risk Management 2019, 15:269-274

Published Date: 11 February 2019

Implications from China patient safety incidents reporting system

Gao XQ, Yan SP, Wu WQ, Zhang R, Lu YL, Xiao SY

Therapeutics and Clinical Risk Management 2019, 15:259-267

Published Date: 8 February 2019

Impact of ST-segment elevation on the outcome of Takotsubo syndrome

Gietzen T, El-Battrawy I, Lang S, Zhou X, Behnes M, Ansari U, Borggrefe M, Akin I

Therapeutics and Clinical Risk Management 2019, 15:251-258

Published Date: 7 February 2019

Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer

Yang R, Wu Y, Yao L, Xu J, Zhang S, Du C, Chen F

Therapeutics and Clinical Risk Management 2019, 15:223-231

Published Date: 4 February 2019

Physical function assessment of older adults with lower body fractures at 3 months post-discharge from hospital

Ibrahim NI, Sharkawi Ahmad M, Zulfarina MS, Zaris SNASM, Nor Azlin ZA, Naina Mohamed I, Mohamed N, Mokhtar SA, Shuid AN

Therapeutics and Clinical Risk Management 2019, 15:201-210

Published Date: 29 January 2019

A good first step for ERAS in otolaryngoiatric field, but not enough

Pelli M, Maggi L, Rocco M

Therapeutics and Clinical Risk Management 2019, 15:187-189

Published Date: 25 January 2019

Uterine fibroids: an update on current and emerging medical treatment options

Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G

Therapeutics and Clinical Risk Management 2019, 15:157-178

Published Date: 23 January 2019

New therapies for the treatment of heart failure: a summary of recent accomplishments

Machaj F, Dembowska E, Rosik J, Szostak B, Mazurek-Mochol M, Pawlik A

Therapeutics and Clinical Risk Management 2019, 15:147-155

Published Date: 22 January 2019

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study

Huang CH, Lai YY, Kuo YJ, Yang SC, Chang YJ, Chang KK, Chen WK

Therapeutics and Clinical Risk Management 2019, 15:103-112

Published Date: 10 January 2019

Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study

Chen Z, Hu B, Feng Y, Wang Z, Jiang X, Cheng Y, He D, Zhu D, Xiao Z, Wang H, Mao Z

Therapeutics and Clinical Risk Management 2019, 15:65-72

Published Date: 28 December 2018

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database

Inada A, Hosohata K, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K

Therapeutics and Clinical Risk Management 2019, 15:59-64

Published Date: 24 December 2018

Is correction of segmental kyphosis necessary in single-level anterior cervical fusion surgery? An observational study

Lu J, Sun C, Bai J, Tian S, Zhang B, Tian D, Kong L

Therapeutics and Clinical Risk Management 2019, 15:39-44

Published Date: 19 December 2018

Sex differences in clinical characteristics and 1-year outcomes of young ischemic stroke patients in East China

Geng C, Lin Y, Tang Q, Tang Y, Wang X, Zhou JS, Yang J, Zheng D, Zhang YD

Therapeutics and Clinical Risk Management 2019, 15:33-38

Published Date: 19 December 2018